Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Receivables - Net (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Receivables - Net for 4 consecutive years, with $448990.0 as the latest value for Q3 2025.

  • On a quarterly basis, Receivables - Net fell 66.17% to $448990.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $448990.0, a 66.17% decrease, with the full-year FY2024 number at $1.1 million, up 40.35% from a year prior.
  • Receivables - Net was $448990.0 for Q3 2025 at bioAffinity Technologies, up from $421869.0 in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.6 million in Q2 2024 to a low of $9930.0 in Q3 2022.
  • A 4-year average of $697075.2 and a median of $811674.0 in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: skyrocketed 11062.28% in 2023, then crashed 73.56% in 2025.
  • bioAffinity Technologies' Receivables - Net stood at $10489.0 in 2022, then skyrocketed by 7638.34% to $811674.0 in 2023, then soared by 40.35% to $1.1 million in 2024, then plummeted by 60.59% to $448990.0 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Receivables - Net are $448990.0 (Q3 2025), $421869.0 (Q2 2025), and $963744.0 (Q1 2025).